Regulations.gov document
Determination that Products Were Not Withdrawn From Sale for Reasons of Safety or…
Notice · FDA-2010-P-0326 · posted Dec 28, 2010
Key facts
| Document ID | FDA-2010-P-0326-0003 |
|---|---|
| Title | Determination that Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness: TRANDATE (Labetalol Hydrochloride) Tablets, 300 Milligrams and 400 Milligrams |
| Document type | Notice |
| Subtype | N-Notice |
| Agency | FDA |
| Docket | FDA-2010-P-0326 |
| Posted | Dec 28, 2010 |
| Federal Register citation | 75 FR 81617 |
| FR document number | 2010-32507 |
| Comment period opens | Dec 28, 2010 |
| Effective date | Dec 28, 2010 |
At a glance
- 1–9 Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: